BTG Specialty Pharmaceuticals
Manufacturing · Pennsylvania, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Falls Corporate Center 300 Conshohocken ...Phone Number
(484) 702-1030Website
www.btgsp.comRevenue
$94.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About BTG Specialty Pharmaceuticals
BTG Specialty Pharmaceuticals provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options.Explore more
BTG Specialty Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BTG Specialty Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once BTG Specialty Pharmaceuticals has new funding data
Click to see if BTG Specialty Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on BTG Specialty Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at BTG Specialty Pharmaceuticals
Product Launch: Get notified when BTG Specialty Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if BTG Specialty Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if BTG Specialty Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
BTG Specialty Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined BTG Specialty Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to BTG Specialty Pharmaceuticals
Compare insights from companies similar to BTG Specialty Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$36.7M
51-200
Private
<$5M
1981
Company Profile Activity
Activity Insights
BTG Specialty Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BTG Specialty Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BTG Specialty Pharmaceuticals.
BTG Specialty Pharmaceuticals Tech Stack
A closer look at the technologies used by BTG Specialty Pharmaceuticals
See more technologies
BTG Specialty Pharmaceuticals News & Media
Largest study to date of high-dose methotrexate associated acute kidney injury supports the use of Voraxaze® (glucarpidase)
Patients receiving glucarpidase had higher adjusted odds of kidney recovery, shorter time to kidney recovery, and a lower mortality rate. Patients receiving glucarpidase had higher adjusted odds of kidney recovery, shorter time to kidney recovery, and a lower mortality rate.BTG International Achieves Finalist Status in Four Categories at the Prestigious Australian Accounting Awards
Sydney, Australia--(Newsfile Corp. - June 8, 2023) - BTG International, one of the leading indirect tax firms in Australia, is proud to announce that it has been selected as a finalist in four categories for the Australian Accounting Awards. Recognised for its exceptional dedication and innovative approach to the industry, BTG is a finalist in the following categories: Firm of the Year, Innovator of the Year, Fast-growing Firm of the Year, and Start-up Firm ofThomas Kolaras Joins SERB and BTG Specialty Pharmaceuticals as US Chief Commercial Officer
Philadelphia, April 11, 2022 (GLOBE NEWSWIRE) -- SERB and BTG Specialty Pharmaceuticals are pleased to announce that Thomas Kolaras has been named the group’s new Chief Commercial Officer for its US business.First Evidence of High-Dose Methotrexate Related Toxicity in Spain Presented at Virtual ISPOR Europe 2021
COPENHAGEN, Denmark, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The first evidence of high dose methotrexate related toxicity (HDMTX) in Spain was presented today at Virtual ISPOR Europe 2021, a global conference on healthcare economics and outcomes. Xavier Badia, MD, MPH, PhD of Omakase Consulting S.L. presented the poster titled “Epidemiology and Clinical Management of Patients with Methotrexate Toxicity in Spain Using the Delphi Technique,” which shows that 11.6% of patients in Spain treated with HDMT
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BTG Specialty Pharmaceuticals
Sign Up For FreeTo access detailed company insights
BTG Specialty Pharmaceuticals provides rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options.... Read More
